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Background: Periodontal disease is suggested to increase the risk of atherothrombotic disease by inducing
dyslipidemia. Recently, we demonstrated that proprotein convertase subtilisin/kexin type 9 (PCSK9), which is known
to play a critical role in the regulation of circulating low-density lipoprotein (LDL) cholesterol levels, is elevated in
periodontitis patients. However, the underlying mechanisms of elevation of PCSK9 in periodontitis patients are
largely unknown. Here, we explored whether Porphyromonas gingivalis, a representative periodontopathic
bacterium, -induced inflammatory response regulates serum PCSK9 and cholesterol levels using animal models.
Methods: We infected C57BL/6 mice intraperitoneally with Porphyromonas gingivalis, a representative strain of
periodontopathic bacteria, and evaluated serum PCSK9 levels and the serum lipid profile. PCSK9 and LDL receptor
(LDLR) gene and protein expression, as well as liver X receptors (Lxrs), inducible degrader of the LDLR (Idol), and
sterol regulatory element binding transcription factor (Srebf)2 gene expression, were examined in the liver.
Results: P. gingivalis infection induced a significant elevation of serum PCSK9 levels and a concomitant elevation of
total and LDL cholesterol compared with sham-infected mice. The LDL cholesterol levels were significantly
correlated with PCSK9 levels. Expression of the Pcsk9, Ldlr, and Srebf2 genes was upregulated in the livers of the P.
gingivalis-infected mice compared with the sham-infected mice. Although Pcsk9 gene expression is known to be
positively regulated by sterol regulatory element binding protein (SREBP)2 (human homologue of Srebf2), whereas
Srebf2 is negatively regulated by cholesterol, the elevated expression of Srebf2 found in the infected mice is
thought to be mediated by P. gingivalis infection.
Conclusions: P. gingivalis infection upregulates PCSK9 production via upregulation of Srebf2, independent of
cholesterol levels. Further studies are required to elucidate how infection regulates Srebf2 expression and
subsequently influences lipid metabolism.
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Periodontitis is associated with atherosclerotic vascular
disease, as it induces dyslipidemia. It has been found that
periodontitis decreases HDL cholesterol and increases
LDL cholesterol levels. It has also been reported that the
presence of periodontal pockets was positively associated
with higher LDL and total cholesterol in humans [1].
Löesche et al. showed that the levels of total and LDL
cholesterol were significantly higher in 50- to 60-year-old
patients with moderate periodontitis compared with age-
and sex-matched controls [2]. Furthermore, intensive
periodontal therapy consisting of subgingival mechanical
debridement with adjunctive local delivery of minocycline
significantly decreased total and LDL cholesterol com-
pared with baseline levels [3]. The mechanisms underlying
the elevation of LDL cholesterol levels in periodontitis
patients have not yet been elucidated.
Plasma cholesterol levels are regulated by the LDL re-
ceptor (LDLR). The number of LDLRs expressed on the
hepatocyte surface is the primary determinant of plasma
cholesterol levels and is therefore strictly regulated.
Transcription of the LDLR gene is controlled by cellular
cholesterol levels through the sterol regulatory element-
binding protein (SREBP) [4] and Liver X receptors
(LXRs) [5]. Additionally, post-transcriptional regulation
of LDLR expression is a major determinant of lipopro-
tein metabolism.
Proprotein convertase subtilisin/kexin type 9 (PCSK9)
post-transcriptionally promotes the degradation of
LDLRs in hepatocytes [6]. PCSK9 is mainly expressed in
the liver, intestine, and kidney, and it is secreted into the
plasma [7]. This protein does not directly degrade
LDLRs but binds to LDLRs at epidermal growth factor-
like repeats. This binding decreases LDLR recycling to
the cell surface and promotes lysosomal degradation [8],
which results in decreased numbers of LDLRs and
increased plasma LDL levels. We have recently shown
that serum levels of PCSK9 are significantly increased in
periodontitis patients compared with periodontally
healthy subjects [9]. In addition to PCSK9, the inducible
degrader of the LDL receptor (Idol) has been shown
to play an important role in the post-transcriptional
regulation of LDLRs. Zelcer et al. [5] found that LDLR
expression is controlled by the LXR-Idol axis as LXR
induces Idol, which is an E3 ubiquitin ligase that triggers
LDLR degradation.
It is well-recognized that infection and inflammation
induce marked changes in lipid and lipoprotein metabol-
ism [10]. However, there is little information about the
effects of infection on PCSK9 or Idol levels and subse-
quent expression of LDLR and cholesterol levels. Only
one study has shown that inflammatory stimuli, such as
lipopolysaccharide or zymosan, markedly increased hep-
atic PCSK9 mRNA expression, resulting in decreasedLDLR protein expression [11]. Therefore, in the present
study, we analyzed the effects of infection with Porphyr-
omonas gingivalis, a representative strain of periodonto-
pathic bacteria, on the regulation of PCSK9 and
subsequently expression of LDLR in the liver.
Results
Serum SAA and PCSK9 levels
Systemic infection with P. gingivalis induced a signifi-
cant elevation of serum amyloid A (SAA) levels. The
PCSK9 levels in the infected mice were significantly
higher than in the sham-infected mice (Figure 1).
Plasma lipid profiles
The total and LDL cholesterol levels were significantly
higher in the P. gingivalis-infected mice compared with
the sham-infected mice. In contrast, HDL cholesterol
levels tended to be lower in the P. gingivalis-infected
mice than the sham-infected mice. There was no differ-
ence in triglyceride levels between the P. gingivalis-
infected mice and sham-infected mice (Figure 2).
Relationship between serum PCSK9 and LDL cholesterol
levels
Similar to a previous study by our group that demon-
strated a close relationship between PCSK9 and LDL
cholesterol, we found a significant correlation between
PCSK9 levels and LDL cholesterol levels after P. gingiva-
lis infection (Figure 3).
However, no correlations were observed between
PCSK9 levels and total cholesterol levels, HDL choles-
terol levels, or triglyceride levels (data not shown).
PCSK9 and LDLR gene and protein expression in the liver
There was a significant increase in the expression of
PCSK9 and LDLR (Figure 4A) in the infected mice com-
pared to the sham-infected mice. However, there was a
much larger increase in gene expression observed for
PCSK9 than LDLR. Although Pcsk9 gene expression was
increased, the levels of mature PCSK9 protein in the
liver of the P. gingivalis-infected mice were similar to
those of the sham-infected mice. Pro-PCSK9 protein
levels were even lower in the P. gingivalis-infected mice
compared with the sham-infected mice. In contrast to
the gene expression results, the protein levels of LDLR
were significantly lower in the livers of the P. gingivalis-
infected mice compared with the sham-infected mice
(Figure 4B and C).
Changes in Srebf2, Lxrs, and Idol gene expression
SREBP2 (Srebf2 in mice) is a major activator of PCSK9
signaling. Therefore, the effect of P. gingivalis infection on
PCSK9 expression was analyzed. As shown in Figure 5A,






































Figure 1 Effects of P. gingivalis infection on serum levels of serum amyloid A (SAA) and PCSK9 (N= 5 in the sham-infected group; N= 6
in the infected group). All samples were analyzed in duplicate for each condition. Box plots represent medians, with the 25th and 75th
percentiles shown as boxes and the 10th and 90th percentiles as whiskers. Significant differences were observed between the infected group and
the sham-infected group (** P< 0.01, Mann–Whitney U-test).
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infected mice.
Because of the important role of Idol in the post-
transcriptional regulation of LDLR expression, the effects
of P. gingivalis infection on Idol gene expression and the
gene expression of Lxrs, a regulator of the Idol gene,
were examined. Idol gene expression was slightly, but
significantly suppressed in the P. gingivalis-infected mice
compared with the sham-infected mice (Figure 5B). How-
ever, no differences in Lxrα or Lxrβ gene expression were
observed, although the expression of both genes tended to
be higher in the P. gingivalis-infected mice (Figure 5C).
Discussion
Given that humans with loss-of-function mutations in
the PCSK9 gene [12] and mice lacking Pcsk9 expression































Figure 2 Effects of P. gingivalis infection on the plasma lipid profile (N
75th percentiles as boxes and the 10th and 90th percentiles as whiskers. Tot
cholesterol levels tended to be lower in the P. gingivalis-infected mice (** Plevels [13], whereas activating mutations in the PCSK9
gene result in severe familial hypercholesterolemia [14]
accompanied by increased cardiovascular risk, PCSK9 is
considered at present to be an important therapeutic tar-
get for combating hypercholesterolemia [15]. In addition,
other factors that elevate circulating PCSK9 levels could
be considered to be risk factors for coronary heart
disease (CHD). A previous study by our group demon-
strated that periodontitis, a chronic inflammatory
disease induced by a group of periodontopathic bacteria,
could elevate serum PCSK9 levels [9]. However, the
underlying mechanisms by which periodontal infection
affects PCSK9 levels and the subsequent alterations of
the plasma lipid profile are not known.
It is well-known that infection and inflammation induce
an acute phase response, which leads to multiple altera-





























=5 in each group). Box plots represent medians, with the 25th and
al and LDL cholesterol levels were significantly higher, whereas HDL
< 0.01, Mann–Whitney U-test).















Figure 3 Relationship between serum PCSK9 and LDL
cholesterol levels in the P. gingivalis-infected (open triangle)
and sham-infected (open circle) mice (N= 5 in each group).
Spearman’s rank correlation coefficient analysis showed that there
was a significant correlation between LDL cholesterol levels and
serum PCSK9 levels. Spearman r = 0.8545, P< 0.01.
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induced downregulation of HDL cholesterol by suppres-
sing Liver X receptors and their target gene Abca1 in
C57BL/6 mice and ApoE-deficient C57BL/6.KOR-Apoeshl
(B6.Apoeshl) mice [16]. Furthermore, as in human peri-
odontitis patients, the LDL cholesterol levels were elevated
in P. gingivalis-infected B6.Apoeshl mice. However, the
molecular basis for the elevation of LDL cholesterol was
not analyzed in this experimental setting.
This study is the first to show that infection induces a
significant increase in circulating PCSK9 levels and a
concomitant decrease of LDLR levels in mice. Further-
more, there was a significant correlation found between
LDLR gene expression in the liver and the serum levels
of PCSK9. In this study, infection was induced via intra-
peritoneal, rather than oral, bacterial inoculation. Al-
though oral infection can mimic human periodontal
disease, and it is clear that oral infection with P. gingiva-
lis does, in fact, affect Pcsk9 gene expression in the liver
(data not shown), subsequent change in lipid metabol-
ism can be easily observed in peritoneal infection model.
Pcsk9 gene expression was significantly upregulated
in the liver of the P. gingivalis-infected mice. Previous
studies have demonstrated that Pcsk9 and Ldlr gene
transcription is regulated by sterol regulatory element-
binding proteins (SREBPs) [17,18]. Consistent with these
studies, Srebf2 expression was found to be significantly
upregulated in the livers of the P. gingivalis-infected
mice compared with the sham-infected mice. Srebf2expression is downregulated by cholesterol and upregu-
lated by statin treatment. As total and LDL cholesterol
were elevated in the P. gingivalis-infected mice, Srebf2 is
likely to be induced by this infection. Although the
mechanisms by which infection and/or inflammation in-
duce the upregulation of Srebf2 are not clear, our study
suggests that additional mechanisms related to infection
induce hyperlipidemia during infection.
Recently, another transcription factor, known as hep-
atocyte nuclear factor-1α (HNF1α), was reported to be
involved in the transcriptional regulation of the Pcsk9
gene in mammalian HepG2 cells [19]. However, it has
not been reported whether Pcsk9 is activated by HNF1α
in mice. Therefore, other mechanisms may regulate
Pcsk9 expression during infection; further studies will be
needed to answer this question.
In contrast to the gene expression results, the level of
mature PCSK9 protein in the liver was unchanged in the
P. gingivalis-infected mice compared to the sham-
infected mice, whereas the levels of PCSK9 proprotein
were slightly reduced in the P. gingivalis-infected mice.
Because we failed to observe the enhanced transcription
of PCSK9 in other organ specimen such as liver, kidney,
jejulium, ilenium, aolta, and spleen (data not shown), we
speculate that secreted PCSK9 immediately infiltrate
into circulation and result in the elevation of PCSK9
levels higher in the P. gingivalis-infected mice. Recently,
it has become evident that domain interactions are im-
portant for the regulation of PCSK9 protein secretion
[20]. However, it remains to be elucidated how infection
affects PCSK9 protein secretion.
Similar to Pcsk9, Ldlr is upregulated in the livers of
the P. gingivalis-infected mice compared with the sham-
infected mice, although to a much lesser degree. Because
LDLR expression is also positively regulated by SREBP2
[18], upregulation of Ldlr could be an effect of the infec-
tion. Contrary to what was observed regarding Ldlr gene
expression, LDLR protein expression in the liver of the
P. gingivalis-infected mice was significantly reduced
compared with the sham-infected mice. Although the
Ldlr gene expression levels in the P. gingivalis-infected
mice were 2 times higher compared with the sham-
infected mice, the expression of LDLR protein was
decreased, possibly because PCSK9 serum levels were
increased more than 20 fold in the infected mice.
In addition to PCSK9, LDLR expression is controlled by
the LXR-Idol axis, in which LXR induces Idol, an E3 ubi-
quitin ligase that triggers LDLR degradation [5]. The im-
portance of Idol in the regulation of LDLR expression is
increasingly being recognized [21]. Therefore, the affect of
P. gingivalis infection on Idol gene expression was ana-
lyzed. Although the expression of the Idol gene was sig-
nificantly down-regulated in the P. gingivalis-infected
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Figure 4 Effect of P. gingivalis infection on PCSK9 and LDLR gene and protein expression in the liver. Total RNA and protein were
extracted from the P. gingivalis-infected and sham-infected mice, and the samples were analyzed by quantitative RT-PCR or western blotting.
Pcsk9 and Ldlr gene expression was significantly higher in the P. gingivalis-infected mice compared with the sham-infected mice (** P< 0.01,
Mann–Whitney U-test). The PCSK9 protein levels of were unchanged in the P. gingivalis-infected mice compared with the sham-infected mice.
LDLR protein levels were significantly lower in the P. gingivalis-infected mice compared with the sham-infected mice († P< 0.05, unpaired t-test).
Miyazawa et al. Lipids in Health and Disease 2012, 11:121 Page 5 of 8
http://www.lipidworld.com/content/11/1/121infected and the sham-infected mice was smaller than
what was observed for Pcsk9. In addition, the expression
of Lxrs did not differ between the P. gingivalis-infected
mice and the sham-infected mice. Therefore, it is possible
that P. gingivalis infection does not affect LDLR expres-
sion by downregulating Idol in this experimental model.
Our study supports the previously described notion that
bacterial infections alter the plasma lipid profile based on
the novel finding that P. gingivalis infection elevates
PCSK9 expression in the liver by increasing Srebf2 expres-
sion through a currently unidentified mechanism. The
effects of infection and inflammation on lipid and lipopro-
tein metabolism are complex, and contrasting results are
often demonstrated between rodents and primates [10].
Our animal study model has potential limitations consid-
ering the characteristics of chronic inflammation in
human periodontitis, because peritoneal infection in mice
induces robust acute immune response. There may be
other proteins that are involved in the regulation ofPCSK9 by the mechanisms related to inflammation. Fur-
ther studies will be required to gain insight into the role of
PCSK9 in the dyslipidemia that accompanies infections
and chronic inflammatory diseases, such as periodontitis.
Conclusions
We found that P. gingivalis infection upregulates PCSK9
production via upregulation of Srebf2, independent of
cholesterol levels resulting elevation of LDL cholesterol.
Further studies are required to elucidate how infection




All experiments were performed in accordance with the
Regulations and Guidelines on Scientific and Ethical
Care and Use of Laboratory Animals of the Science































































Figure 5 Comparison of the relative gene expression levels in the liver between the P. gingivalis-infected mice and the sham-infected
mice (N= 5 in the sham-infected group, N = 6 in the infected group). The relative mRNA levels for the investigated genes were normalized
to the relative glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels. The box plots represent medians, with the 25th and 75th
percentiles being depicted as boxes and the 10th and 90th percentiles presented as whiskers. Significant differences were observed for Srebf2 and
Idol (* P< 0.05, Mann–Whitney U-test).
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Niigata University (permit number 231–1). Six-week-old
male C57BL/6 mice were obtained from Japan SLC, Inc.
(Shizuoka, Japan). The mice were maintained under
pathogen-free conditions and were fed regular chow and
sterile water until they were infected.
Bacterial cultures and infection
P. gingivalis strain W83 was cultured in modified Gifu
anaerobic medium (GAM) broth (Nissui, Tokyo, Japan) in
an anaerobic jar (Becton Dickinson Microbiology Systems,
Cockeysville, MD) in the presence of an AnaeroPack™
(Mitsubishi Gas Chemical Co. Inc., Tokyo, Japan) for
48 hours at 37°C. Bacterial suspensions were prepared in
Mg2+/Ca2+-free phosphate-buffered saline (PBS) using spec-
trophotometry to establish growth curves. The number of
CFUs was standardized by measuring the optical density at
600 nm. The mice in the experimental groups were admi-
nistered a single intraperitoneal (i.p.) inoculum of 109 CFU
in 0.2 ml of sterile phosphate-buffered saline (PBS), pH 7.2.
Control mice were inoculated with PBS alone. Mice were
euthanized 16 hrs after infection and then analyzed.
Real-time PCR
Total RNA was isolated from the liver using TRIzol™
(Life Technologies, Carlsbad, CA) according to themanufacturer's instructions. Next, aliquots of RNA were
reverse transcribed to produce cDNA using random pri-
mers (Takara Bio Inc., Shiga, Japan) and M-MLV reverse
transcriptase (Life Technologies, Carlsbad, CA). Specific
primers and probes for real-time PCR were purchased
from Applied Biosystems (Foster City, CA). TaqMan
Gene Expression Assays (Applied Biosystems) were per-
formed in 20-μl reactions containing 900 nM primers
and 250 nM probe using an ABI PRISM 7900HT
Sequence Detection System (Applied Biosystems). The
reaction conditions involved a 10-minute incubation at
95°C followed by 40 cycles of a two-step amplification
procedure consisting of annealing/extension at 60°C for
1 minute and denaturation for 15 seconds at 95°C. ABI
PRISM SDS 2.0 software (Applied Biosystems) was used
to analyze the standards and quantify the data. The rela-
tive quantity of each mRNA sequence was normalized to
the relative quantity of glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) mRNA.
Western blotting
The livers of the mice were dissected into small pieces,
and protein was extracted using T-PER Tissue Protein
Extraction Reagent (Thermo Scientific, Rockford, IL)
supplemented with a Halt Protease Inhibitor Cocktail
Kit (Thermo Scientific) and Halt Phosphatase Inhibitor
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turer’s instructions. Cell debris was pelleted by centrifu-
gation at 10,000× g for 5 minutes at 4°C. The protein
concentration in the supernatant was determined using
the Pierce BCA Protein Assay kit (Thermo Scientific)
according to the manufacturer’s instructions.
Thirty micrograms of each sample were solubilized in
SDS sample buffer, separated by SDS-PAGE, and trans-
ferred to a polyvinylidene difluoride membrane (Immo-
bilon-P; Millipore Co., Bedford, MA). The samples were
subsequently subjected to western blotting with rabbit
anti-mouse PCSK9 (Abcam, Cambridge, UK) or rabbit
anti-mouse LDLR (Abcam) primary antibodies followed
by ECL™ Peroxidase labeled anti-rabbit secondary anti-
bodies (GE Healthcare, Buckinghamshire, UK). The blots
were developed with ECL using Lumi Vision PRO
400EX (Aisin, Aichi, Japan). The membranes were then
washed 3 times with wash buffer (Tris-buffered saline
containing 0.1% Tween-20 and 0.5% BSA) and reprobed
with goat anti-mouse GAPDH antibodies (Santa Cruz
Biotechnology, Santa Cruz, CA), as described above.
Horseradish peroxidase-labeled donkey anti-goat IgG
(Santa Cruz) was used as secondary antibody for reprob-
ing. The intensity of the signal was quantified with Scion
Image 4.02 computer software. The intensity of each
protein band was normalized to the intensity of
GAPDH.
Serum PCSK9, SAA, and lipoprotein levels
SAA and PCSK9 were measured using commercially
available ELISA kits (Tridelta Development Ltd., Kildare,
UK and R & D Systems, Minneapolis, MN, respectively)
in serum collected prior to euthanasia. Serum choles-
terol and triglyceride profiles were analyzed at Skylight
Biotech Inc. (Akita, Japan).
Statistical analyses
The differences in the examined gene expression and
biochemical parameters between the infected and con-
trol mice were analyzed using the Mann–Whitney U-
test. Linear correlations were obtained using Spearman’s
rank correlation coefficient analysis. Unpaired t-tests
were used for densitometric analysis. The statistical ana-
lyses were performed using standard statistical software
(GraphPad Prism, GraphPad Software Inc., La Jolla, CA
and StatView J-5.0 application program, SAS Institute
Inc., Cary, NC). P < 0.05 was considered to be statisti-
cally significant.
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